Esperion Therapeutics
ESPR
#7490
Rank
C$0.47 B
Marketcap
$2.39
Share price
5.70%
Change (1 day)
-15.25%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): C$9.08 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.33 Billion. , an increase over its 2023 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 C$10.75 M-104.99%
2023 -C$0.22 Billion-15.03%
2022 -C$0.26 Billion-20.61%
2021 -C$0.32 Billion84.28%
2020 -C$0.18 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.29 Billion19.57%
2017 -C$0.25 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$70.59 Million36.45%
2014 -C$51.73 Million43.55%
2013 -C$36.04 Million145.26%
2012 -C$14.7 Million
2002 -C$41.89 Million-7.81%
2001 -C$45.44 Million15.03%
2000 -C$39.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.73 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.77 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.92 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.84 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$41.2 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.29 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA